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Objective(s): The first graduating 05 resident class prepares to enter
the job market in the summer of 2012, and this survey seeks to understand
the perception of the surgical community of this training paradigm.
Methods: An anonymous online survey was emailed to 148 surgery
chairpersons and 2193 Society for Vascular Surgery (SVS) members in
the United States and Canada, and responses were received from, respec-
tively, 37 (25%) and 302 (14%). Respondents were asked about their
practice background, residency program, hiring patterns, and percep-
tions of the 05 training.
Results: SVS respondents were from academic (63%) and private (37%)
practices and included staff surgeons (62%), program directors (15%), and
division chiefs (22%). Only 34% had a 05 program, and 58% had a vascular
surgery fellowship. Of the respondents, 11% take general surgery call, and
93% are likely to hire a new vascular surgeon in the next 5 years. Only 32%
thought that 05 residents have the same level of surgical maturity and 36%
thought that they have the same level of open operative skills as 52
trainees. However, 67% believed that 05 residents will be prepared for
practice on graduation, and 83% thought that they will have endovascular
skills equal to 52 trainees. Another 34% thought 05 residents will need
additional fellowship training in open surgery. The chairpersons had similar
perceptions as SVS members. SVS members (88%) and chairpersons (86%)
would interview a 05 graduate for a faculty position; 83% and 72%,
respectively, would consider hiring. Ninety-three percent of respondents
who currently have a 05 program and 77% of those who do not would
consider hiring a 05 graduate. SVS members (62%) and chairpersons
(51%) believed the 05 paradigm is essential for the advancement of
vascular surgery.
Conclusions: Overall perceptions of 05 graduates are positive and
indicate they are likely to be accepted into the vascular surgery workforce.
Although there are some reservations regarding the maturity level and open
operative skills of 05 graduates, further follow-up will be required to
evaluate their performance in clinical practice.
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Objective(s): Extracorporeal membrane oxygenation (ECMO) pro-
vides continuous long-term cardiopulmonary support. It has been spec-
ulated that patients undergoing ECMO via femoral arterial cannulation
are more prone to develop peripheral vascular complications. The pur-
pose of this study was to evaluate the incidence of peripheral vascular
complications in this group of patients and outline the modalities used to
treat these complications.
Methods: Data were collected for all patients who had femoral
artery cannulation for ECMO therapy from June 2008 to October 2011.
Primary outcome was any vascular complication. Secondary outcomes
were 30-day mortality and amputation. Operative reports were reviewed
to analyze the surgical procedures implied for treating vascular compli-
cations.
Results: During this time period, 101 patients (63.4% men, mean
age 47.7 years) underwent ECMO therapy. Indications included cardio-
genic shock in 61 (60.4%), pulmonary failure in 37 (36.6%), and com-
bined cardiac and pulmonary failure in three (3%). Overall mortality was
42%, and 28% among those had vascular complications (P  .30).
Peripheral vascular complications developed in 18 patients (17.8%; 95%
confidence interval, 10%-25%; Table): two (11%) were managed nonop-
eratively and 16 (89%) needed surgical intervention. Eight patients
(44.4%) required femoral endarterectomy with patch angioplasty. One
patient required below knee amputation. None of these patients needed
distal bypass.
Conclusions: Vascular complications among ECMO patients can
typically be treated with femoral reconstruction. Development of vascu-
lar complications in ECMO patients does not appear to increase the risk
of amputation or death.
Table. Treatment of vascular complications
Vascular
complications No. Management No (%)
Mortality
No. (%)
Acute ischemia of
lower
extremity
8 Removal of ECMO
catheter
8/8 (100) 3/8 (37)
Diagnostic angiogram 1/8 (12.5) 0/8 (0)
Primary repair of
common femoral
artery
2/8 (25) 0/8 (0)
Femoral endarterectomy
with patch angioplasty
4/8 (50) 0/8 (0)
Difficult insertion
because of
arterial
calcifications
3 Femoral endarterectomy
with patch angioplasty
3/3 (100) 1/3 (33.3)
Iliac artery stent
placement
1/3 (33.3) 0/3 (0)
Laceration of
common
femoral artery
2 Primary repair 2/2 (100) 0/2 (0)
Pseudoaneurysm
of external iliac
artery
2 Nonoperative
management
1/2 (50) 1/2 (50)
Covered stent placement 1/2 (50) 0/2 (0)
ECMO, Extracorporeal membrane oxygenation.
Routine Ambulatory Medical Care Fails to Diagnose Patients With
Abdominal Aortic Aneurysms at Risk for Rupture
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Objective(s): This study investigated whether routine ambulatory
medical evaluation by a nonvascular surgeon and the one-time screening
ultrasound examination that is approved by Congress through the Screening
Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act are adequate
for diagnosing abdominal aortic aneurysm (AAA) before rupture.
Methods: A retrospective record review was performed of all pa-
tients with ruptured AAA (rAAA) during a 7-year period. All patients
who were evaluated in an ambulatory care setting 6 months of the date
of rupture were identified. The outpatient encounter was reviewed, and
clinical data were collected. These data were compared with clinical data
collected from the date of rupture.
Results: Between January 2004 and December 2010, 160 patients were
diagnosed with rAAA. Four patients were excluded due to misdiagnosis. Of the
remaining 156 patients, 53 (34%) were evaluated as outpatients by nonvascular
surgeons6months of the date of rupture and form the basis of this study. There
were 37men (70%), their average agewas 73.5 years, average bodymass indexwas
28 kg/m2, and average AAA size was 75 mm. A physical examination of the
abdomen was documented in 37 of the 53 (70%) the encounters. Two (5%) had
tenderness to palpation and three (8%) had a pulsatile mass. When the 53 patients
with rAAAwere evaluated by the vascular surgery service on the date of rupture, 28
(53%) had tenderness to palpation (P .0001) and 26 (49%) had a pulsatile mass
(P .0001). Only 10 of these 53 patients (19%) would have been eligible for the
screening abdominal ultrasound scan under the SAAAVEAct.
Conclusions: Routine medical evaluation in the ambulatory care set-
ting along with the one-time screening ultrasound examinagion offered by
Medicare are suboptimal tools for detecting AAA before rupture. Further-
more, even in the hands of trained vascular surgeons who are evaluating
patients for possible rAAA, history and physical examination findings are
diagnostic only half of the time.We need to rethink the screening process for
patients at risk for AAA.
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Objective(s): Diversity among health care providers is felt to be an
important component in addressing health care disparities and may help
improve patient communication. Caucasian men have historically repre-
sented vascular surgery (VS). We hypothesized that the 5-year integrated VS
residency paradigm might foster increased diversity.
Table. Applicants in vascular surgery training
% Independent (52) % Integrated (05)
Year Female Cauc Black Asian
Nat
Am Other
No
resp Female Cauc Black Asian
Nat
Am Other
No
resp
2007 15.8 54.2 5.2 25.2 0.0 4.5 11.0 0 83.3 0.0 0.0 0.0 16.7 0.0
2008 18.3 60.0 6.9 23.1 0.8 2.3 6.9 16.1 41.2 5.3 28.1 0.0 13.2 12.3
2009 19.5 63.7 4.8 15.3 0.0 4.0 12.1 22.1 39.6 5.8 24.0 0.0 11.0 19.5
2010 26.3 53.8 6.7 23.5 0.0 3.4 12.6 20.3 38.9 9.7 28.3 0.9 8.3 14.0
2011 27.1 53.5 3.1 29.4 0.7 4.6 11.6 22.9 54.1 1.9 18.5 0.6 8.2 26.1
First year residents in integrated vascular
residency First year fellows in vascular surgery
# Female # Male
% Female in PGY
1 year # Female # Male
% Female in first
year fellowship
2007 0 6 0% 15 104 13%
2008 3 11 21% 16 99 14%
2009 5 17 23% 18 99 15%
2010 9 18 33% 14 109 13%
2011 17 12 59% 20 94 18%
Methods: Applicant sex and race status listed on the Electronic Resi-
dent Application System (ERAS) from 2007 to 2011 was evaluated on all
applications to integrated (5-year) VS residencies and fellowships (2 year).
Sex data were available for all of VS Accredited Council for Graduate
Medical Education (ACGME) integrated residencies and fellowships. VS
training programs were also reviewed to determine diversity of program
directors and faculty.
Results: Female applicants to VS integrated programs increased 20-
fold during the 5-year study period, from 0 (0%) in 2007 to 69 (22.9%) in
2011, compared with a 1.7-fold increase in fellowship applicants. African
American applicants to integrated programs during the study period ranged
from 0% to 9.7% and Asian applicants from 0% to 28.3% (Table). There were
no women (0%) in the 2007 integrated intern class and 17 (59%) in the 2011
postgraduate year 1 class, compared with 15 (13%) and 20 (18%), respec-
tively, in the fellowships. Of 32 integrated VS programs in 2010, three
(9.4%) program directors were women, one (3.1%) was Asian, and 22
(68.7%) were Caucasian men. Of the 101 VS fellowship program directors,
seven (6.9%) were women, six (5.9%) were Asian, and 74 (73.2%) were
Caucasian men. One or more female VSs were on staff at 20 (62.5%) of the
VS divisions that had integrated training programs.
Conclusions: Redesigning training in VS appears to appeal to women,
with less effect on race. There remains room to increase diversity among
trainees, program directors, and faculty in VS training programs.
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Objective(s): The Belgian-Italian Trial Investigating Abbott Vascular
Vascular Iliac Stents in the Treatment of TASC A, B, C and D Iliac Lesions
(BRAVISSIMO) study is a prospective, nonrandomized, multicenter trial,
conducted at 12 Belgian hospitals and 11 Italian hospitals. The objective is
to evaluate the long-term (24-month) outcome of the self-expanding nitinol
Absolute Pro (Abbott Vascular) and the balloon-expandable Omnilink Elite
(Abbott Vascular) stent in TransAtlantic InterSociety Concensus (TASC) A
and B and TASC C and D iliac lesions. A separate analysis of both patient
populations is performed.
Methods: Primary study end point is primary patency at 12 months,
defined as a target lesion without a hemodynamically significant stenosis
(50%, systolic velocity ratio 2.0) on duplex ultrasound imaging and
without target lesion revascularization (TLR) 12 months. The study
included 325 patients, of which 190 presented with TASCA or B lesions and
135 with TASC C or D lesions. Analysis is performed comparing the results
of the TASC A/B cohort with the results of the TASC C/D cohort.
Results: The study included 131 patients with TASC A, 59 with TASC
B, 54 with TASC C, and 82 with TASC D aortoiliac lesions. Demographic
data were comparable for all TASC patient groups. Of the TASC A patients,
85 received Omnilink Elite stents, 45 received Absolute Pro stents, and one
received both stents. Of the TASC B patients, 24 received Omnilink Elite
stents, 24 received Absolute Pro stents, and mixed stent use was reported in
two patients. In the TASC C group, 14 patients were treated with Onmilink
Elite, 34 with Absolute Pro, and six with both stents. Of the TASC D
patients, 29 received the Omnilink Elite, 35 received the Absolute Pro, and
18 received both. The 12-month primary patency rates were uniformly high,
without statistically significant differences among TASC groups: A, 94%; B,
96%; C, 91%; and D, 88%. Stratified by stent use, 12-month primary patency
rates were 96% for self-expanding stents, 90% for balloon-expandable stents,
and 84% for the 27 patients treated with both types (P  .03).
Conclusion: Primary endovascular treatment of symptomatic iliac
artery occlusive disease produces 12-month patency 88% irrespective of
TASC classification. On the basis of these findings, endovascular therapy
should be considered the treatment of choice for this condition; primary
aortofemoral bypass is no longer indicated for isolated iliac artery occlusive
disease.
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Objective(s):During the past decade, the treatment of popliteal aneu-
rysms has evolved at our institution from the sole operative intervention
during the initial part of the study period, to combined surgical and
endovascular treatment, and finally, to endovascular-centered management
in more recent years. Outcomes among treatment modalities for popliteal
aneurysms were assessed.
Methods: This is a retrospective review of all patients with popliteal
aneurysms treated at our institution from 2001 to 2011. Data collection
included the indication for intervention, treatment details, interventional
patency, limb salvage, perioperative outcome, and long-term survival.
Results: During this period, 88 aneurysms were treated in 72 patients.
Indications for intervention included 47 (53%)with symptomatic presentations,
and 41 (47%) were asymptomatic. Treatment included endovascular exclusion
in 24, surgical repair in 63 (14 posterior approach and 49medial approach with
bypass and exclusion), and primary amputation in one patient. Nine aneurysms
(10.2%) received catheter-directed thrombolysis (Fig). Demographics were
similar between the two treatment cohorts, except for age, with endovascular
stenting patients significantly older (76.0 vs 66.0 years, P  .002). The mean
length of stay was 3.9 vs 9.5 days (P .001), favoring endovascular treatment.
Therewere no perioperative (30-day) deaths in the endovascular group and one
death in the surgical cohort. The mean patency follow-up was 18.5 vs 28.3
months. Primary patency did not differ between endovascular and surgically
treated patients at 1 year (92.3% vs 83.3%,P .26) and3 years (61.5% vs 77.8%,
P  .89). No limbs were lost in the endovascular group during the follow-up
period of 22.4months.One late limb loss occurred in the surgical cohort (mean
follow-up, 29.2 months). The long-term survival rate was 65% in the endovas-
cular patients (mean follow up, 33.9months) and 80.8% in the surgical patients
(mean follow up, 42.9 months, P .22).
Conclusions: Endovascular treatment of popliteal aneurysms provides
similar short-term patency to that of the traditional gold standard approach
Fig.
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